Ultra Fast.
Ultra Reliable.
miDiagnostics is developing a portfolio of molecular diagnostic tests, where quality, speed, and accuracy are key factors to support healthcare professionals in their diagnosis, ultimately enhancing patient care.
Products
Simple. Fast. Accurate.
miDiagnostics’ mission is to revolutionize healthcare by developing innovative, high-quality molecular diagnostic solutions that deliver fast, accurate, and reliable results.
Silicon Chip
Passive liquid processing
Ultra-fast PCR
Micro-channel network with nanometer precision
PCR Card
Compatible with different
sample types
QR barcode reader
for tracebility
Single use
Embedded with silicon chip
Small sample size required
Reader
Multiple use
Connectivity
Thermal and optical
processing capabilities
Small footprint – portable
Computer
Reduced footprint with built-in barcode scanner and full-size touchscreen
Flexible wired, wireless and off-line network connection capabilities
Secure login with individual access codes for data privacy
Intuitive User Interface with easy to interpret results
Software
Support the most common protocols for lab information system (LIS)
Sample to answer traceability, results archive, printing and exporting
Remote software updates and device diagnostics
Silicon-based Innovations.
miDiagnostics is revolutionizing diagnostics by reinventing high precision liquid control and ultra-fast PCR.
This is enabled by silicon chip technology, which is at the heart of our approach. It allows high precision liquid control and ultra-fast PCR.
This disruptive technology enables miDiagnostics to offer high-precision, fast testing at a low cost via a specially designed test-card. We aim to disrupt the traditional diagnostics industry in the same way microprocessors changed electronics, from mainframe computers to portable tablets.
“miDiagnostics has the potential to disrupt and transform the industry by making diagnostic information available to clinician and patient alike.”
“Its easy-to-use and cost-efficient test will revolutionize point-of-care testing by directly engaging with patients and enabling speedy intervention.”
“Proud to be leading a top team and together with our numerous partners to make a significant contribution to healthcare in general.”
“As a Non-Executive Director on miDiagnostics’ Board, I have been privileged to witness its continued development. I am very proud to see many years of hard work coming to fruition and providing value, facilitating the return to a normal way of life, with potential to move high quality testing closer to the patient.”
“This technology could aid the management of outbreaks in challenging settings, such as nursing homes and home care environments, allowing healthcare professionals to adjust their management decisions at the point of care. ”
